Onconova Therapeutics (ONTX) Announces Quarterly Earnings Results, Beats Expectations By $0.12 EPS
Onconova Therapeutics (NASDAQ:ONTX) announced its earnings results on Thursday. The company reported ($0.77) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.89) by $0.12, ARN reports.
Shares of Onconova Therapeutics (NASDAQ:ONTX) opened at 5.11 on Thursday. Onconova Therapeutics has a 52-week low of $4.10 and a 52-week high of $31.13. The stock’s 50-day moving average is $5.02 and its 200-day moving average is $6.7. The company’s market cap is $110.6 million.
Onconova Therapeutics, Inc (NASDAQ:ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.